Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hematology
•
Neurology
•
Vascular Neurology
How do you manage acute ischemic stroke patients secondary to HUS/TTP?
Is there a certain platelet value cutoff that you would consider adding antithrombotics?
Related Questions
What is your recommended long term management of extensive dural venous sinus thrombosis in an otherwise healthy young patient?
How to approach reversal of TNK in hemorrhagic conversion of ischemic stroke?
How long would you continue chronic transfusion therapy for adult sickle cell patients who have had a stroke?
What is the utility of a hypercoagulability workup in recurrent cryptogenic stroke, and what specific tests would you recommend?
What is your clinical threshold for treating a potential monoclonal gammopathy of thrombotic significance?
Can anti-cardiolipin or anti-beta-2 glycoprotein antibodies cause prolonged PTT in the absence of a lupus anticoagulant?
In ischemic stroke patients with low LDL levels (<30-50 mg/dl), would you consider lowering LDL levels to lower values without concern for any side effects?
How do you determine which patients with ICAS are the best candidates for balloon angioplasty versus those who should continue with aggressive medical management alone?
Is there benefit of early initiation of antiplatelet therapy or DVT prophylaxis in patients who present with large MCA infarcts and are being considered for hemicraniectomy?
At what point should aspirin therapy for stable cardiovascular disease be discontinued in patients with a diagnosis of chronic cerebral microbleeds or possible Cerebral Amyloid Angiopathy?